Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correct Use of Sequential Formoterol and Budesonide via Aerolizer in Asthma
NCT00997477Phase 4Withdrawn
- Sponsor
- Novartis
- Start
- Jun 2010
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of formoterol, budesonide in asthma, sponsored by Novartis. Planned start Jun 2010; status: withdrawn.
02
Drugs
formoterolbudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00997477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00997477.